TARA SHAPICH: Open Payments
NPI 1053374199 · BELLEFONTE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$996 in 65 payments from 17 companies in 2025. Trend: 2023 $269 · 2024 $600 · 2025 $996
Food & beverage: $996
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $178 |
| ABBVIE INC. | 11 | $166 |
| PFIZER INC. | 13 | $154 |
| GlaxoSmithKline, LLC. | 5 | $103 |
| Lilly USA, LLC | 5 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $68 |
| Exact Sciences Corporation | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $25 |
Products named: Ozempic, QULIPTA, NURTEC ODT, MOUNJARO, XIFAXAN, UBRELVY, PREVNAR 20, AREXVY.
Industry payments across PA — which companies pay providers there.
